Blend Labs Q2 2024 Adj. EPS $(0.02) Beats $(0.04) Estimate, Sales $40.480M Beat $39.012M Estimate
Portfolio Pulse from Benzinga Newsdesk
Blend Labs (NYSE:BLND) reported Q2 2024 adjusted EPS of $(0.02), beating the analyst estimate of $(0.04). Sales were $40.480M, also surpassing the $39.012M estimate. Despite the beats, sales decreased by 5.45% year-over-year.
August 08, 2024 | 9:56 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Blend Labs reported better-than-expected Q2 2024 earnings and sales, with EPS of $(0.02) beating the $(0.04) estimate and sales of $40.480M surpassing the $39.012M estimate. However, sales decreased by 5.45% year-over-year.
The better-than-expected EPS and sales figures are likely to have a positive short-term impact on BLND's stock price. However, the year-over-year decline in sales may temper some of the enthusiasm.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100